An open-label study of TAK-536 in hypertensive patients with renal disorder

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220835

Enrollment

Registered

2009-09-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

investigational material(s) Generic name etc : TAK-536 INN of investigational material : Therapeutic category code : 214 Antihypertensives Dosage and Administration for Investigational material : Onc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Hypertension with renal disorder 2.Inpatient/Outpatient status: Outpatient, etc.

Exclusion criteria

Exclusion criteria: 1.Presence of secondary hypertension other than renal parenchymal hypertension, grade III hypertension, or malignant hypertension 2.Renal disorder associated with collagen disease (e.g., SLE) or rapidly progressive glomerulonephritis 3.Cardiac disease, cerebrovascular disorder, vascular disease, or advanced hypertensive retinopathy 4.Renovascular hypertension or renal artery stenosis 5.Undergoing dialysis 6.Hyperkalemia, etc.

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026